ENOXAPARIN ROVI®
ACTIVE PRINCIPLE:
Enoxaparin Sodium
INDICATION:
venous thrombosis
DATE:
27/02/2018
STATUS:
Authorized
Biosimilar medicine authorized by the AEMPS
ACTIVE PRINCIPLE:
Enoxaparin Sodium
INDICATION:
venous thrombosis
DATE:
27/02/2018
STATUS:
Authorized
Subscribe to receive a weekly summary of current events on biosimilar medicines in your email.